Abstract
There are no special recommendations for basic vaccinations in patients with chronic neurological deficits distinct from the nationwide advocated schedule in Switzerland. Reports describing adverse neurological events possibly related to vaccinations have attracted public attention. It is unclear if patients with chronic neurological deficits are more reluctantly vaccinated compared to healthy children. We therefore investigated the acceptance of vaccinations in such patients and healthy controls in a retrospective case-control study. At the University Children’s Hospital, Basel, Switzerland we investigated 100 patients with chronic neurological deficits and 200 age-matched healthy controls regarding the issue of vaccination rates and ages. The total number of administered vaccinations against diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b (Hib), mumps, measles, rubella and hepatitis B were significantly lower in patients compared to healthy controls ( P <0.01 for each of the respective vaccines). Patients had an increased risk to receive the third pertussis, diphtheria, and tetanus vaccinations (relative risks (RR) for late vaccination 1.53, 1.53, and 1.54 respectively, P <0.01 for all comparisons), the second (RR=1.60, P <0.05) and third Hib vaccinations (RR=1.52, P <0.05), and the third polio vaccination (RR=1.43, P <0.05) later than controls. Conclusion:Children with chronic neurological deficits received fewer vaccinations than healthy controls. In addition, patients received vaccinations later than healthy children. Hence, it may be assumed that children with chronic neurological deficits are at an increased risk to acquire preventable infections. Therefore, vaccination should be promoted as part of the consultation during a routine appointment with the specialist.
Similar content being viewed by others
Abbreviations
- DTP :
-
diphtheria, tetanus, pertussis
- hep B :
-
hepatitis B
- Hib :
-
Haemophilus influenzae type B
- MMR :
-
mumps, measles and rubella
- RR :
-
relative risk
References
Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP et al (2001) Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group: the risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med 345: 656–661
Brody M, Sorley RG (1947) Neurologic complications following administration of pertussis vaccine. NY State J Med 47: 1016–1017
Bundesamt für Gesundheit der Schweiz (Swiss Federal Health Bureau) (1999) Repräsentative Erhebung zur Durchimpfung in der Schweiz 1998. Bulletin 20: 356–361
Campbell JR, Szylagyi PG, Rodewald LE, Winter NL, Humiston SG, Roghmann KJ (1994) Intent to immunize among pediatric and family residents. Arch Pediatr Adolesc Med 148: 926–929
Center for Disease Control and Prevention (2001) National, state, and urban area vaccination coverage levels among children age 19–35 months – United States 2000. JAMA 286: 1169–1170
Cherry JD (1990) Pertussis vaccine encephalopathy: it is time to recognize it as the myth that it is. JAMA 263: 1679–1680
Committee on Infectious Diseases (1991) The relationship between pertussis vaccine and brain damage: reassessment. Pediatrics 88: 397–400
Davis RL, Rubanowice D, Shinefield HR, Lewis N, Gu D, Black SB et al (1999) Immunization levels among premature and low birth-weight infants and risk factors for delayed up-to-date immunization status. JAMA 282: 547–553
Desgrandchamps D (1998) Routine vaccination schedule in childhood. Ther Umsch 55: 8–12
Fenichel GM (1999) Assessment: neurologic risk of immunization: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 52: 1546–1552
Grand MG, Wyll SA, Gehlbach SH, Landrigan PJ, Judelsohn RG, Zendel SA et al (1972) Clinical reactions following rubella vaccination. A prospective analysis of joint, muscular, and neuritic symptoms. JAMA 220: 1569–1572
Heininger U (2001) Recent progress in clinical and basic pertussis research. Eur J Pediatr 160: 203–213
Howson CP, Fineberg HV (1992) The ricochet of magic bullets: summary of the Institute of Medicine Report, adverse effects of pertussis and rubella vaccines. Pediatrics 89: 318–324
Kempe A, Steiner JF, Renfrew BL, Lowery E, Haas K, Berman S (2001) How much does a regional immunization registry increase documented immunization rates at primary care sites in rural Colorado? Ambul Pediatr 1: 213–216
Lauberau B, Hermann M, Schmitt HJ, Weil J, von Kries R (2002) Detection of delayed vaccinations: a new approach to visualize vaccine uptake. Epidemiol Infect 128: 185–92
MacKay IR, Rosen FS (2001) Vaccines and vaccination. N Engl J Med 345: 1042–10537
Madsen T (1933) Vaccination against whooping cough. JAMA 101: 187–188
Meszaros JR, Asch DA, Baron J, Hershey JC, Kunreuther H, Schwartz-Buzaglo J (1996) Cognitive processes and the decisions of some parents to forego pertussis vaccination for their children. J Clin Epidemiol 49: 697–703
Ovetchkine P (2001) Secondary effects of vaccinations. Arch Pediatr 8: 316–320
Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltola H (2000) Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J 19: 1127–1134
Szylagyi PG, Rodewald LE, Humiston SG, Hager J, Roghmann KJ, Doane C et al (1994) Immunization practices of pediatricians and family physicians in the United States. Pediatrics 94: 517–523
Tillmann BU, Tillmann HC, Nars PW, Weber P (2001) Vaccination rate and age of premature infants <1500 g in north-western Switzerland. Acta Paediatr 90: 1421–1426
Vivier PM, Alario AJ, Peter G, Leddy T, Simon P, Mor V (2001) An analysis of the immunization status of preschool children enrolled in a statewide Medicaid managed care program. J Pediatr 139: 624–629
Acknowledgements
This study could not have been performed without the help of many colleagues and nurses of the University Children’s Hospital in Basel, Switzerland. We thank each of them for their contribution, especially R. Bubl, U. Blauenstein and V. Grote. We thank C. Schindler, Institute of Social and Preventive Medicine, University of Basel, Switzerland, for expert statistical advice.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tillmann, B.U., Tillmann, HC., Heininger, U. et al. Acceptance and timeliness of standard vaccination in children with chronic neurological deficits in north-western Switzerland. Eur J Pediatr 164, 320–325 (2005). https://doi.org/10.1007/s00431-005-1627-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-005-1627-x